Stratos Wealth Partners LTD. Owns $498,000 of stock in CME Group Inc. (NASDAQ:CME)


Stratos Wealth Partners LTD. lifted its position in CME Group Inc. (NASDAQ: CMEGet a rating) by 6.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The company held 2,093 shares of the financial services provider after acquiring an additional 126 shares during the period. The holdings of Stratos Wealth Partners LTD. in CME Group were worth $498,000 at the end of the last quarter.

A number of other hedge funds also changed their holdings in the company. Exchange Traded Concepts LLC increased its stake in CME Group by 42.5% in the 1st quarter. Exchange Traded Concepts LLC now owns 21,790 shares of the financial services provider worth $5,183,000 after purchasing an additional 6,495 shares during the period. Waverton Investment Management Ltd increased its stake in CME Group by 0.8% during the 1st quarter. Waverton Investment Management Ltd now owns 714,459 shares of the financial services provider worth $169,941,000 after buying an additional 5,882 shares during the period. Robeco Institutional Asset Management BV increased its holding in CME Group shares by 93.9% during the 1st quarter. Robeco Institutional Asset Management BV now owns 45,490 shares of the financial services provider worth $10,819,000 after acquiring an additional 22,031 shares in the last quarter. Ieq Capital LLC increased its stake in CME Group shares by 25.8% during the 1st quarter. Ieq Capital LLC now owns 4,970 shares of the financial services provider worth $1,182,000 after acquiring an additional 1,020 shares in the last quarter. Finally, FNY Investment Advisers LLC bought a new position in CME Group stock during Q1 for a value of approximately $47,000. 86.71% of the shares are currently held by institutional investors and hedge funds.

The CME group grew by 1.2%

Shares of CME Group Shares opened at $201.94 on Friday. The company has a fifty-day simple moving average of $201.09 and a two-hundred-day simple moving average of $222.14. CME Group Inc. has a 1-year low of $185.79 and a 1-year high of $256.94. The company has a market capitalization of $72.58 billion, a price/earnings ratio of 26.36, a P/E/G ratio of 4.18 and a beta of 0.44. The company has a debt ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ: CMEGet a rating) last reported results on Wednesday, April 27. The financial services provider reported earnings per share of $2.11 for the quarter, beating analyst consensus estimates of $2.00 by $0.11. CME Group achieved a return on equity of 9.29% and a net margin of 57.98%. The company posted revenue of $1.35 billion in the quarter, versus a consensus estimate of $1.33 billion. In the same quarter last year, the company earned earnings per share of $1.79. The company’s revenue increased 7.4% year over year. Research analysts expect CME Group Inc. to post EPS of 7.92 for the current year.

CME Group announces dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 27. Shareholders of record on Friday, June 10 received a dividend of $1.00 per share. This represents a dividend of $4.00 on an annualized basis and a dividend yield of 1.98%. The ex-dividend date was Thursday, June 9. CME Group’s dividend payout ratio is currently 52.22%.

Wall Street analysts predict growth

CME has been the subject of several research reports. Atlantic Securities upgraded CME Group shares from a “neutral” rating to an “overweight” rating and set a price target of $235.00 for the company in a Friday, June 10 research note. StockNews.com launched a hedge on CME Group shares in a research note on Thursday, March 31. They set a “holding” rating for the company. UBS Group lowered its price target on CME Group shares from $258.00 to $246.00 and set a “buy” rating for the company in a Wednesday July 6 research note. Credit Suisse Group cut its price target on CME Group shares from $242.00 to $233.00 and set a “neutral” rating for the company in a Wednesday, July 6 research note. Finally, Morgan Stanley raised its price target on CME Group shares from $255.00 to $271.00 and gave the company an “equal weight” rating in a Wednesday, April 13 research note. One equity research analyst gave the stock a sell rating, nine gave the stock a hold rating and seven gave the stock a buy rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $242.20.

About CME Group

(Get a rating)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures contracts and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indices, currencies, agricultural commodities, energy and metals, as well as fixed income products.

See also

Want to see what other hedge funds hold CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ: CMEGet a rating).

Institutional ownership by quarter for CME Group (NASDAQ:CME)



Get news and reviews for CME Group Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for CME Group and related companies with MarketBeat.com’s free daily email newsletter.